Pharmaceutical Regulation and Registration Procedures in Japan
Online Course Course

Pharmaceutical Regulation and Registration Procedures in Japan

  • Dates 18 April 2024
  • Location Zoom
  • Hours 5 hours
  • Language English
  • Hours 16:00-21:00 Brussels
  • 15:00-20:00 UK
  • 10:00am-03:00pm New York
$700 Until 23 Mar 2024
$780 Until 11 Apr 2024
$900 Until 18 Apr 2024
About the Course
Dror Wohlfeiler
Lecturer: Dror Wohlfeiler
Dr. Dror Wohlfeiler is a seasoned pharmaceutical professional with more than 30 years of experience gained working in the EU, US, Israel, Japan and other Asian countries, in site, regional and corporate roles.
Headed the Japan specialty and generic R&D project development at Teva from 2007 to 2017. Before 2007 acted as head of Quality Control for Teva’s operation division.
Built and managed teams in branded and generic R&D, supervised global project teams for Phase I - III drug developments resulting in more than 100 approved ANDA submissions, 2 NDA’s and numerous Phase 3 trials in Japan.
Used to work and live for 4 years in Japan started at t Kowa-Teva JV as the head o

THE REGULATORY AFFAIR ENVIRONMENT IN JAPAN

Understand how to successfully navigate the Japanese health authorities and bring pharmaceutical products into the Japanese market.

This course will provide:

  • A thorough overview and in-depth case studies on how to successfully navigate the Japanese health authorities and bring pharmaceutical products onto the Japanese market.
  • The do’s and don’ts of constructive interactions with Japanese colleagues and officials
  • The participant will become familiar with the contents of drug files, and the Japanese regulatory system, including the Pharmaceuticals and Medical Devices Agency (PMDA) and the Ministry of Health, Labor and Welfare (MHLW).
  • The regulatory procedures will be discussed throughout the drug development phases and how to successfully consult with PMDA, e.g, in the clinical trial notification phase.
  • You will get the latest trends in Japanese pharmaceutical regulations and procedures.
  • Understand the Japanese drug development and post-approval framework and regulatory procedure in CMC, clinical and regulatory audits.
  • The company will be benefited from an employee who understands the Japanese drug development, post-approval framework and regulatory procedures and a regulatory professional who can make recommendations on how to achieve project goals in the shortest possible development time
  • A regulatory professional who can play an important strategic role in project teams working on obtaining a marketing authorization in Japan

Related Courses

Picture Of Anat Sakov
Anat Sakov
Course Hours 04 June 2024

Sample Size Selection in a Clinical Trial

Picture Of Johann Daniel Weyer
Johann Daniel Weyer
Course Hours 16 May 2024

Data Management for Non-Data Managers

Picture Of Joseph Tyler
Joseph Tyler
Course Hours 26 June 2024

Effective Utilization and Management of Contract Development and Manufacturing Organizations (CDMO’s)

Picture Of Joseph Tyler
Joseph Tyler
Course Hours 19 June 2024

Best Practices for CMC Section Preparation for IND’s and IMPD’s